January 12, 2021 Jaguar Health (NASDAQ: JAGX) wasn’t a common topic of conversation prior to December 2020. However, breathtaking price moves have recently put JAGX stock in the limelight, practically forcing healthcare sector traders to take notice. Source: Bukhta Yurii / Shutterstock.com Yet, these are not your run-of-the-mill medical treatment options. The company’s wholly owned subsidiary, Napo Pharmaceuticals, develops and commercializes treatments based on rainforest-area plants. Is this a niche market worth pursuing? A glance at the price action of JAGX stock should answer that question. Just suffice it to say that the company and the stock are moving quickly — and making the short sellers run for the hills.